| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/08/2004 | US20040067246 Topical solution containing a chromane or chromene derivative |
| 04/08/2004 | US20040067245 Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin |
| 04/08/2004 | US20040067243 Enhancedly-solubilized beta-hydroxy acids and higher potency skin peels formulated therefrom |
| 04/08/2004 | US20040067242 Multi-subtype FIV vaccines |
| 04/08/2004 | US20040067241 Comtrol a/k/a Virex antiviral composition |
| 04/08/2004 | US20040067237 Using a rational selection of representative PspAs from various families of clades to produce broadly efficacious Pneumococcal vaccines |
| 04/08/2004 | US20040067224 Enternal formulation |
| 04/08/2004 | US20040067222 Regulation of glucocorticoid concentration |
| 04/08/2004 | US20040067216 Drugs comprising ion exchange resins complexed with heterocyclic amines, used for prophylaxis or prevention of viral diseases such as acquired immune deficiency syndrome |
| 04/08/2004 | US20040067215 Antiobestic agents and health foods |
| 04/08/2004 | US20040067212 Skin conditioner |
| 04/08/2004 | US20040067211 Emulsion composition |
| 04/08/2004 | US20040067209 Dermatological compositions and methods |
| 04/08/2004 | US20040067199 Conjugates with radionuclides; radiotherapy; tumor diagnosis |
| 04/08/2004 | US20040065748 Scent strip |
| 04/08/2004 | DE20217814U1 Melatonin-Tagesdosierungseinheiten Melatonin daily dosage units |
| 04/08/2004 | DE10245624A1 Oral pharmaceutical composition comprises the thrombin inhibitor ethyl 3-(2-(4-(hexyloxycarbonylamidino)phenylaminomethyl)-1-methyl-1H-benzimidazole-5-carbonyl)-2-pyridylamino)propionate and an organic acid |
| 04/08/2004 | DE10245212A1 Säurehaltige Desensibilisierungsmittel für Zähne Acidic desensitizing agent for teeth |
| 04/08/2004 | DE10244681A1 Neue feste Telmisartan enthaltende pharmazeutische Formulierungen und deren Herstellung New solid pharmaceutical formulations containing telmisartan and their preparation |
| 04/08/2004 | DE10244504A1 Schnellfreisetzende Darreichungsform mit schwerlöslichem Wirkstoff Fast-release dosage form sparingly soluble drug |
| 04/08/2004 | CA2689424A1 Methods for treatment and/or prevention of retinal disease |
| 04/08/2004 | CA2633589A1 Perivascular wraps |
| 04/08/2004 | CA2500461A1 Antiseptic solutions containing silver chelated with polypectate and edta |
| 04/08/2004 | CA2500420A1 Anti-neurodegenerative agents |
| 04/08/2004 | CA2500415A1 Amino acid composition for improving central nervous function |
| 04/08/2004 | CA2500360A1 Methods and compositions for the treatment of autoimmune disorders using clofarabine |
| 04/08/2004 | CA2500220A1 Composition for stimulating bone-formation and bone consolidation |
| 04/08/2004 | CA2500210A1 Cholesterol efflux and uses thereof |
| 04/08/2004 | CA2500200A1 Small organic molecules that increase the activity of gelatinase a in ocular cells |
| 04/08/2004 | CA2500198A1 Combined use of methylphenidate and melatonin for treating attention-deficit hyperactive disorder |
| 04/08/2004 | CA2500196A1 Caspase inhibitors as anticancer agents |
| 04/08/2004 | CA2500091A1 Methods and compositions for the treatment of lupus using clofarabine |
| 04/08/2004 | CA2500067A1 Apparatus and method for delivery of mitomycin through an eluting biocompatible implantable medical device |
| 04/08/2004 | CA2499983A1 Docohexaenoic acid for improved glycemic control |
| 04/08/2004 | CA2499876A1 Piperidine derivatives |
| 04/08/2004 | CA2499872A1 Cross-linked polymer matrices, and methods of making and using same |
| 04/08/2004 | CA2499826A1 Cell separation compositions and methods |
| 04/08/2004 | CA2499818A1 Compositions for the inhibition of protein kinase c alpha for treatment of diabetes mellitus and cardiovascular diseases |
| 04/08/2004 | CA2499817A1 Derivatives comprising sterols and/or stanols and specific classes of anti-inflammatory agents and use thereof in treating or preventing cardiovascular disease |
| 04/08/2004 | CA2499738A1 Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes |
| 04/08/2004 | CA2499689A1 Heterocyclic compound for stimulating or inducing hair or eyelash growth and/or for slowing down hair loss, composition containing same, and uses thereof |
| 04/08/2004 | CA2499533A1 Use of excipients to increase dna uptake by swine muscle cells |
| 04/08/2004 | CA2499501A1 Prophylactic docosahexaenoic acid therapy for patients with subclinical inflammation |
| 04/08/2004 | CA2499497A1 Substituted pyrimidines |
| 04/08/2004 | CA2499253A1 Nucleoside derivatives for treating hepatitis c virus infection |
| 04/08/2004 | CA2499170A1 Methods and compositions for treatment of neurological disorder |
| 04/08/2004 | CA2499038A1 Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| 04/08/2004 | CA2499036A1 1,3,5-triazines for treatment of viral diseases |
| 04/08/2004 | CA2498423A1 Combination drug |
| 04/08/2004 | CA2497765A1 8-hydroxy substituted adenine compounds and uses thereof |
| 04/08/2004 | CA2497280A1 Novel piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 04/08/2004 | CA2495338A1 Pyrazole amides for treating hiv infections |
| 04/08/2004 | CA2492468A1 .beta.-hydroxyphenylalkylamines and their use for treating glaucoma |
| 04/07/2004 | EP1405913A2 Process for improving the production of 5R clavams |
| 04/07/2004 | EP1405860A1 Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use |
| 04/07/2004 | EP1405855A1 A kind of oligosaccharides, their sulfates and dendrimers, and the uses of these compounds |
| 04/07/2004 | EP1405852A1 Diamine derivatives |
| 04/07/2004 | EP1405848A1 Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient |
| 04/07/2004 | EP1405646A2 Pharmaceutically acceptable salts of local anaesthetics with anti-inflammatory compounds and methods for preparing the same |
| 04/07/2004 | EP1405644A1 Tissue-specific transporter inhibitor |
| 04/07/2004 | EP1405640A1 Novel immunosuppressants |
| 04/07/2004 | EP1405639A1 Use of sodium channel blocking compounds and aspirin in manufacturing drugs for producing synergistic analgesic effect in mammals |
| 04/07/2004 | EP1405638A1 Medicinal composition for treatment of interstitial cystitis |
| 04/07/2004 | EP1405637A1 Remedies for amyotrophic lateral sclerosis (als) |
| 04/07/2004 | EP1405636A1 Function regulator for retinoid relative receptor |
| 04/07/2004 | EP1405633A1 Composition, particularly for cosmetics containing an aromatic aminoketone |
| 04/07/2004 | EP1405074A2 P5CRS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 04/07/2004 | EP1404873A2 Chimeric immunomodulatory compounds and methods of using the same |
| 04/07/2004 | EP1404871A2 Method for treatment of cancer associated with elevated her 2 levels |
| 04/07/2004 | EP1404863A1 PIBs AS MODIFIERS OF THE P53 PATHWAY AND METHODS OF USE |
| 04/07/2004 | EP1404861A1 Methods and kits for diagnosing a pancreatic-based fat malabsorption disorder |
| 04/07/2004 | EP1404860A2 Delivery system for nucleic acids |
| 04/07/2004 | EP1404853A1 Process for the production of allicin |
| 04/07/2004 | EP1404841A2 Cyp1b1 nucleic acids and methods of use |
| 04/07/2004 | EP1404831A2 Type 2 cytokine receptor and nucleic acids encoding same |
| 04/07/2004 | EP1404714A2 Nuclear hormone receptor ligand binding domain |
| 04/07/2004 | EP1404710A2 Identification of ses-3 (spr-5) in c. elegans and the uses of the same |
| 04/07/2004 | EP1404704A1 Bridged bicyclic serine protease inhibitors |
| 04/07/2004 | EP1404701A1 Method for preparing oestrogen derivatives |
| 04/07/2004 | EP1404700A2 Process for the production of 6,7-dihydroxy steroid compounds by allylic oxidation of steroid-5-ene compounds to steroid-5-ene-7-one compounds followed by hydroboration and oxidation and intermediates of this process |
| 04/07/2004 | EP1404694A1 Nucleoside compounds in hcv |
| 04/07/2004 | EP1404693A2 C12 modified erythromycin macrolides and ketolides having antibacterial activity |
| 04/07/2004 | EP1404689A1 Oxaliplatin active substance with a very low content of oxalic acid |
| 04/07/2004 | EP1404686A1 Aryl boronate functionalized polymers for treating obesity |
| 04/07/2004 | EP1404685A1 Aryl boronic acids for treating obesity |
| 04/07/2004 | EP1404682A1 Method of inhibiting ptp 1b and/or t-cell ptp and/or other ptpases with an asp residue at position 48 |
| 04/07/2004 | EP1404679A2 (hetero)aryl substituted benzofurans as 5-ht ligands |
| 04/07/2004 | EP1404678A1 Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture |
| 04/07/2004 | EP1404677A1 Imidazotriazines for use as phosphodiesterase inhibitors |
| 04/07/2004 | EP1404676A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 04/07/2004 | EP1404675A1 Dpp-iv-inhibiting purine derivatives for the treatment of diabetes |
| 04/07/2004 | EP1404674A2 Quinuclidine-substituted heteroaromatic compounds as ligands at nicotinic acetylcholine receptors |
| 04/07/2004 | EP1404672A1 Tyrosine kinase inhibitors |
| 04/07/2004 | EP1404671A1 Macrocycles useful in the treatment of alzheimer's disease |
| 04/07/2004 | EP1404669A2 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases |
| 04/07/2004 | EP1404668A1 Variolin derivatives and their use as antitumor agents |
| 04/07/2004 | EP1404667A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/07/2004 | EP1404665A1 Antimicrobial and radioprotective compounds |
| 04/07/2004 | EP1404664A1 Aminediols for the treatment of alzheimer's disease |
| 04/07/2004 | EP1404663A1 Eurotinone and derivatives thereof, method for the production and use of the same |